Related Topics News -

     
 < Previous page   Detail   |   Print 
     
中國抗體SM17臨床試驗完成首例受試者給藥
2023-11-28T  
中國抗體舒西利單抗新藥研究申請獲受理
2023-11-16T  
中國抗體首創治療產品SM17新藥研究申請獲批
2023-09-12T  
中國抗體-B治療類風濕關節炎藥物獲藥監局受理生物製品許可申請
2023-09-05T  
《公司業績》中國抗體中期虧損收窄至1.34億人民幣
2023-08-22T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.